Witness the major breakthroughs of microbial research and application pertaining to challenges like medicinal data interpretation, investment and regulatory hurdles faced by the practitioners. Detect the non-identified dysbiosis, to discover the potential areas under study for investments in Gut and Skin microbiome and its role as a diagnostic tool of pharmaceutical discovery.
Join us at Microbiome- Advanced Therapeutics and Sequencing Congress, 2019 to network with biotech, pharma, academicians and investors to exchange views and observe the most ingenious research and technologies. Get addressed to the non-bacterial component and role of microbiome in clinical applications and preventative medicine.